Pulse Biosciences Inc. has announced new inducement grants for its newly hired principal accounting officer, Steven T. Weber, and four other employees. These grants, approved by the company's Compensation Committee, involve options to acquire up to 68,217 shares of the company's common stock, beyond the existing 2017 Equity Incentive Plan, under the 2017 Inducement Equity Incentive Plan. Mr. Weber's options, totaling up to 27,500 shares, are split evenly between time-based vesting over four years and performance-based objectives tied to market-capitalization milestones. The options, with an exercise price of $16.03 per share, were issued in compliance with Nasdaq Listing Rule 5635(c)(4).
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.